This trial was funded by Eli Lilly, the manufacturer of Zepbound (tirzepatide), which participated in the data collection and analysis, although the article was written by the academic researchers
CPT Code 0786T Effective January 1, 2024, the CPT Editorial Panel separated integrated from non-integrated ( i.e., traditional) sacral neurostimulator procedure by establishing a new CPT code, 0786T to report procedures using integrated sacral neurostimulator devices, while CPT code 64590 was updated to reflect the use of traditional technology: 0786T: Insertion or replacement of percutaneous electrode array, sacral, with integrated neurostimulator, including imaging guidance, when performed
Because its not just water
However, the consequences can be more serious for older adults: severe hypoglycemia increases the risk of falls by 70%